Client News

Home/Client News
Client News 2018-08-28T11:24:45+00:00
March 15, 2018
Rockwell Medical Reports Fourth Quarter and Year End 2017 Results
WIXOM, Mich., March 15, 2018 (GLOBE NEWSWIRE) -- Rockwell Medical, Inc. (RMTI), a fully-integrated biopharmaceutical company targeting end-stage renal disease (ESRD) and chronic kidney disease ...
March 15, 2018
CymaBay Reports Fourth Quarter and Fiscal 2017 Financial Results and Provides Corporate Update
NEWARK, Calif., March 15, 2018 (GLOBE NEWSWIRE) -- CymaBay Therapeutics, Inc. (CBAY), a clinical-stage biopharmaceutical company focused on developing therapies for liver and other chronic ...
March 15, 2018
Checkpoint Therapeutics Reports Fourth Quarter and Full-Year 2017 Financial Results and Recent Corporate Highlights
NEW YORK, March 15, 2018 (GLOBE NEWSWIRE) -- Checkpoint Therapeutics, Inc. (“Checkpoint”) (CKPT), a clinical-stage, immuno-oncology biopharmaceutical company focused on the acquisition, development and commercialization ...
March 15, 2018
BioTime Reports Fourth Quarter and Fiscal 2017 Results
BioTime, Inc. (NYSE American: BTX), a clinical-stage biotechnology company focused on degenerative diseases, today reported financial results for the fourth quarter and fiscal year ended December ...
March 15, 2018
BioDelivery Sciences Reports Fourth Quarter and Full-Year 2017 Financial Results and Provides Corporate Update
RALEIGH, N.C., March 15, 2018 (GLOBE NEWSWIRE) -- BioDelivery Sciences International, Inc. (BDSI) today reported financial results for the fourth quarter and year ended December ...
March 15, 2018
Bellerophon Provides Business Update and Reports Fourth Quarter and Full-Year 2017 Financial Results
WARREN, N.J., March 15, 2018 (GLOBE NEWSWIRE) -- Bellerophon Therapeutics, Inc. (BLPH) (“Bellerophon” or the “Company”), a clinical-stage biotherapeutics company, today provided a business update and ...
March 15, 2018
Innate Pharma to present broad and innovative portfolio in immuno-oncology at AACR 2018
Marseille, France, March 15, 2018, 07:00 AM CET - Innate Pharma SA (the "Company" - Euronext Paris: FR0010331421 - IPH) today announces that new clinical and ...
March 15, 2018
Transgene to Present Data on a Novel Viral Vector with Superior Anti-Cancer Immunotherapeutic Activity at AACR 2018
STRASBOURG, France--(BUSINESS WIRE)--Regulatory News: Transgene (Euronext Paris: TNG), a biotech company that designs and develops virus-based immunotherapies, will be presenting a poster with new and encouraging ...
March 15, 2018
AC Immune prepares for a first in human study of a promising positron emission tomography (PET) tracer for Parkinson's disease
Lausanne, Switzerland, March 15, 2018 - AC Immune SA (ACIU), a Swiss-based, clinical stage biopharmaceutical company with a broad pipeline focused on neurodegenerative diseases, today ...
March 15, 2018
UroGen Reports Fourth Quarter and Full Year 2017 Financial Results
RA’ANANA, ISRAEL and NEW YORK, March 15, 2018 (GLOBE NEWSWIRE) -- UroGen Pharma Ltd. (URGN), a clinical-stage biopharmaceutical company developing treatments to address unmet needs ...
March 15, 2018
Aptose to Present New CG’806 and APTO-253 Data at the 2018 AACR Annual Meeting
SAN DIEGO and TORONTO, March 15, 2018 (GLOBE NEWSWIRE) -- Aptose Biosciences Inc. (“Aptose” or the “Company”) (APTO) (APS.TO), a clinical-stage company developing highly differentiated ...
March 15, 2018
VBL Therapeutics Announces Year End 2017 Financial Results
TEL AVIV, Israel, March 15, 2018 (GLOBE NEWSWIRE) -- VBL Therapeutics (VBLT), a clinical-stage biotechnology company focused on the discovery, development and commercialization of first-in-class ...
March 15, 2018
Mustang Bio Announces Key Leadership Appointments
NEW YORK, March 15, 2018 (GLOBE NEWSWIRE) -- Mustang Bio, Inc. (“Mustang”) (MBIO), a Fortress Biotech (FBIO) Company focused on the development of novel immunotherapies ...
March 15, 2018
Checkpoint Therapeutics Announces Preclinical Data Presentation at the 2018 American Association for Cancer Research Annual Meeting
NEW YORK, March 15, 2018 (GLOBE NEWSWIRE) -- Checkpoint Therapeutics, Inc. (“Checkpoint”) (CKPT), a clinical-stage, immuno-oncology biopharmaceutical company focused on the acquisition, development and commercialization ...
March 15, 2018
Albireo Reports Fourth Quarter and Year-End 2017 Financial Results
BOSTON, March 15, 2018 (GLOBE NEWSWIRE) -- Albireo Pharma, Inc. (ALBO), a clinical-stage orphan pediatric liver disease company developing novel bile acid modulators, today announced ...
March 15, 2018
La Jolla Pharmaceutical Company Announces Pricing of Public Offering of Common Stock
SAN DIEGO, March 15, 2018 (GLOBE NEWSWIRE) -- La Jolla Pharmaceutical Company (LJPC) (La Jolla), a leader in the development of innovative therapies intended to ...
March 15, 2018
New Data on Molecular Templates’ Engineered Toxin Bodies to be Presented at the American Association of Cancer Research (AACR) Annual Meeting 2018
AUSTIN, Texas, March 15, 2018 (GLOBE NEWSWIRE) -- Molecular Templates, Inc., (MTEM) a clinical stage biopharmaceutical company focused on the discovery and development of Engineered ...
March 15, 2018
Minerva Neurosciences to Host Key Opinion Leader Meeting on the Negative Symptoms of Schizophrenia on Thursday, March 22
WALTHAM, Mass., March 15, 2018 (GLOBE NEWSWIRE) -- Minerva Neurosciences, Inc. (NERV), a biopharmaceutical company focused on the development of therapies to treat central nervous ...
March 14, 2018
EDAP TMS SA : EDAP TMS to Announce Year End 2017 Financial Results on Tuesday, March 27, 2018
LYON, France, March 14, 2018 - EDAP TMS SA (EDAP), the global leader in therapeutic ultrasound, today announced that it will release its financial results ...
March 14, 2018
Onxeo Provides Financial Update
PARIS--(BUSINESS WIRE)--Regulatory News:Onxeo S.A. (Euronext Paris, NASDAQ Copenhagen: ONXEO FR0010095596), a biotechnology company specializing in the development of innovative drugs in oncology, and notably rare ...
Page 58 of 117